Position in NVS
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$600,237
+$15,205 QoQ
Shares Held
3,830
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#812
of 1,603 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Twin Lakes Capital Management, LLC holds $10,825,505 across 8 Drug Manufacturers - General names. NVS ranks #3 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
58,267 | $7,361,452 | |
| 2 | JNJ |
Johnson & Johnson
|
6,478 | $1,645,217 | |
| 3 | NVS |
Novartis AG
This page
|
3,830 | $600,237 | |
| 4 | LLY |
ELI LILLY & Co
|
325 | $389,814 | |
| 5 | PFE |
Pfizer Inc
|
15,868 | $382,101 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
4,781 | $275,481 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,328 | $170,648 | |
| 8 | OGN |
Organon & Co.
|
41 | $555 |
All Filings in NVS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $600,237 | 3,830 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $585,032 | 3,830 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $538,382 | 3,905 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $500,777 | 3,905 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $472,544 | 3,905 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $435,329 | 3,905 | Shares | Sole | 2025-05-23 | |
| 2024-12-31 | $379,995 | 3,905 | Shares | Sole | 2025-02-19 | |
| 2024-09-30 | $449,153 | 3,905 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $415,726 | 3,905 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $377,730 | 3,905 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $394,287 | 3,905 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $397,763 | 3,905 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $394,053 | 3,905 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $358,064 | 3,892 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $343,738 | 3,789 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $288,001 | 3,789 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $320,284 | 3,789 | Shares | Sole | 2022-08-18 | |
| 2022-03-31 | $336,258 | 3,832 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $326,962 | 3,738 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $305,693 | 3,738 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $341,055 | 3,738 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $318,413 | 3,725 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $343,441 | 3,637 | Shares | Sole | 2021-02-26 | |
| No filing history on record for this holder in this stock. | ||||||